Beta Bionics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $19.18. The average 1-year stock price forecast is 22.40% higher than the current stock price, while the lowest is $13 (-17.04%) and the highest is $32 (+104.21%).

Price Target: $19.18 (+22.40%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$13	$19.18	$18	$32
Change	-17.04%	+22.40%	+14.87%	+104.21%

Analyst Ratings

The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	8	7	7	7	7
Buy	1	1	1	1	1	1
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Buy Reiterates $20	Buy	Reiterates	$20	+27.63%	Jun 24, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Buy Reiterates $20	Buy	Reiterates	$20	+27.63%	Jun 22, 2026
David Roman Goldman Sachs	Goldman Sachs	Buy Maintains $19 → $17	Buy	Maintains	$19 → $17	+8.49%	May 27, 2026
Richard Newitter Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 22, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Hold Reiterates $11 → $13	Hold	Reiterates	$11 → $13	-17.04%	May 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

133.68M

from 100.25M

33.34%

from 100.25M

Revenue Next Year

180.80M

from 133.68M

35.25%

from 133.68M

EPS This Year

-2.11

from -1.38

EPS Next Year

-2.39

from -2.11

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	179.00K	12.00M	65.12M	100.25M	133.68M
Revenue Growth	-	6,601.12%	442.93%	53.94%	33.34%
Gross Profit	179.00K	6.31M	35.89M	55.54M	77.97M
Gross Margin	100.00%	52.59%	55.11%	55.40%	58.33%
Operating Income	-64.74M	-35.85M	-45.25M	-71.68M	-106.15M
Net Income	-64.75M	-44.10M	-54.76M	-73.20M	-99.27M
EPS	-	-	-	-1.38	-2.11
Free Cash Flow	-	-19.66M	-35.24M	-40.90M	-117.00M
No. Analysts	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	137.9M
Avg	133.7M
Low	131.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	37.6%
Avg	33.3%
Low	30.7%

EPS Forecast

EPS	2026	2027	2028
High	-1.79
Avg	-2.11
Low	-2.38

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-